Dos Santos, Gaël
Seifert, Harry A.
Bauchau, Vincent
Shinde, Vivek
Barbeau, Dominique M.
Cohet, Catherine
Article History
First Online: 17 April 2017
Compliance with ethical standards
:
: GlaxoSmithKline Biologicals SA took in charge all costs associated with the development and publication of the present manuscript.
: Gaël Dos Santos reports he was employed by Business & Decision Life Sciences on behalf of GSK at the time of the study and is now employed by the GSK group of companies. Harry A. Seifert, Vincent Bauchau, Dominique M. Barbeau and Catherine Cohet are employees of the GSK group of companies. Gaël Dos Santos, Harry A. Seifert, Vincent Bauchau, Dominique M. Barbeau and Catherine Cohet hold shares in the GSK group of companies as part of their employee remuneration. Vivek Shinde reports he was employed by GSK at the time of the signal investigation and is now employed by Novavax Vaccines, and holds shares in the GSK group of companies.
: Ethical approval and patient consent were not required during this investigation.